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Dear Editors, 
We read with great interest the results of the PROMISE study by Flynn et al. [1], which shows 
the association of maternal viral load and CD4 count with perinatal HIV-1 transmission. Only 
two infants acquired HIV-1, despite apparent undetectable or detectable but less than 40 
copies/mL maternal viral load. These cases may well represent true episodes of transmission 
in the presence of undetectable viral replication and the authors discuss potential reasons 
including cell-free RNA of cell associated HIV-DNA in breast milk. 
The PARTNER study [2] aimed at assessing whether the HIV transmission risk through 
condomless sex among serodifferent gay men in the context of virally suppressive ART was 
below an acceptable low level, defined as one infection per 500 couple years of follow up. By 
this, the second U of U = U (undetectable equals untransmittable) became a quantifiable 
statistically risk. This landmark study provided compelling evidence to support the U = U 
campaign for sexual transmission. Specifically the absence of any phylogenetically linked 
transmission in the PARTNER study turned into a crucially supportive argument. However, 
would a single case of sexual HIV-1 transmission from someone with an undetectable HIV-
RNA disprove this conclusion?  
We think that the PROMISE study results are consistent with those from the PARTNER study 
in statistically supporting that U = U for breastfeeding HIV-infected women and the risk of 
transmission to their infants. In the PARTNER study, the relevant exposure to risk of HIV 





Copyright  20 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. 21
study corresponds to the frequency of breastfeeding episodes. Looking at it this way, both 
studies demonstrate vanishingly small risk per episode. In fact, PROMISE provides more 
information about how small the risk is, as one can see from the width of the confidence 
intervals below. 
In the PARTNER study, zero transmissions were observed in 76,088 condomless sexual acts 
over 1,593 eligible couple-years of follow-up provided by 782 HIV serodiscordant couples. 
This gives an incidence rate of 0 with 95% interval (0.00, 4.85) per 100,000 condomless 
sexual acts. To calculate the incidence rate for mother-to-child HIV transmission through 
beast-feeding, one has make assumptions about the frequency of feeds during the average 
70 weeks of follow-up in the PROMISE trial. We think eight to 12 times per day is a 
reasonable assumption for the first few weeks with decreasing rates over time. We assumed 
the following mean frequencies for different ages: 0-12 weeks (W): 8-12 times, 12-24W: 6-8 
times, 24-48W: 6 times, 48-70W: 4 times. This gives an average of 3,052 episodes of breast-
feeding per child over 70 weeks and a total of about 1,227*3,052 = 3,744,804 breast-feeding 
episodes that could have yielded two HIV infections at a HIV-RNA of less than 40 copies/mL 
in the PROMISE trial. This gives an estimated incidence rate of 0.053 HIV transmissions with 
95% CI: (0.006, 0.193) per 100,000 breast-feeding episodes. 
As much as successful antiretroviral therapy (ART) can enable people to avoid condom use to 
prevent HIV transmission, successful maternal ART that results in undetectable maternal 
HIV-1 plasma viral load can enable mothers to breast-feed. Like for the sexual transmission U 
= U [2], pregnant women with HIV need access to testing, effective treatment, viral load 
monitoring to reach viral loads less than 50 copies/mL, and support to reach and maintain 
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pregnant. This will enable them to discuss and jointly decide with their HIV-physicians 
whether they can breastfeed their baby with acceptable evidence-based low level risk. 
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